FDA Warning Letter — Laveeza (nmi) Bhatti, M.D., Principle Investigator
The FDA took a Warning Letter action against Laveeza (nmi) Bhatti, M.D., Principle Investigator on August 4, 2017 (Beverly Hills, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Laveeza (nmi) Bhatti, M.D., Principle Investigator
- Date
- August 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Beverly Hills, CA (United States)